Markedsdata leveret af TwelveData og Morningstar
Greenland Mines Ltd is a diversified company focused on natural resources and cell and gene therapy. Its mining business centers on the exploration and development of the Skaergaard Project in Southeast Greenland, where it targets palladium, gold, and platinum deposits. The company also maintains a biotechnology segment developing therapies aimed at neurodegenerative and age-related disorders, including candidate treatments for conditions such as ALS, Alzheimer’s disease, and Parkinson’s disease. Through this combination of critical minerals exploration and advanced therapeutic research, Greenland Mines Ltd operates across two distinct markets that serve industrial and healthcare applications. Based in Charlotte, North Carolina, the company is positioned as a niche participant in both the mining and biotechnology sectors.